Clinical Trials

The purpose of this study is to perform studies to identify mutations in ACTA2, MYH11, and potentially other genes in individuals with with arterial aneurysms and/or dissections with clinical suspicion for connective tissue disease.

The eventual goal of this study is to identify genetic and proteomic markers that may influence susceptibility to vascular diseases including peripheral arterial disease, pulmonary hypertension, carotid artery stenosis, arterial aneurysmal disease, fibromuscular dysplasia, congenital heart disease and other less common diseases that affect the blood vessels.